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Sp=61%) and MRI (Se=56% Sp=92%). ROC analysis showed that, in comparison to the
combination of ECG, SAECG, Hol and ETT, the area under the curve did not differ signif-
icantly for their combination with MRI.
Conclusion: This study demonstrates that an ECG offers the highest sensitivity and the
SAECG offers the highest specificity in diagnosing ARVD. MRI offers high specificity but
its combination with the ECG, SAECG, ETT and Hol does not improve the utility of the
other tests significantly. 
1127-105 Transient Left Ventricular Apical Ballooning Syndrome: 
A US Case-Series
Kevin A. Bybee, Abihiram Prasad, Gregory W. Barsness, Joseph G. Murphy, Allan S. 
Jaffe, Amir Lerman, R. Scott Wright, Charanjit S. Rihal, Mayo Clinic and Foundation, 
Rochester, MN
Background: Transient left ventricular apical ballooning syndrome (TLVABS) is a distinct
form of acute reversible left ventricular dysfunction which was initially described in Japan.
It’s frequency and clinical presentation in the U.S. is unclear. This is one of the first
descriptions of the syndrome in a U.S. population.
Methods: We identified 10 patients during the year 2002 who had: 1) apical LV ballooning
with akinesis or dyskinesis extending beyond a single major coronary artery distribution;
2) a coronary angiogram revealing no stenosis greater than 70%; 3) new ST segment/T
wave changes on the presenting electrocardiogram. We investigated the clinical charac-
teristics and short-term outcome of these patients with TLVABS.
Results: All patients were white females; mean age 71.5+12.0 years. Presenting symp-
toms were chest pain in 5, dyspnea in 3, and chest pain and dyspnea in 2 patients. Eight
had at least 1 mm of ST elevation in contiguous leads, typically V2-V5. The QTc was >
500ms in seven patients with a mean QTc of 519 ms+50 ms for all patients. All patients
had troponin T and/or CK-MB elevations. The highest recorded median peak troponin T
and CK-MB values were 0.59 ng/ml (25th-75th percentile 0.33-0.93 ng/ml) and 14.1ng/ml
(9.7-26.9 ng/ml), respectively. An identifiable preceding acute emotional or physiologic
stressor was present in 8 of 10 patients. All coronary stenosis in patients with CAD were
< 50%, except for 1 patient with a chronic 60% mid-LAD lesion. The mean LVEF at
admission was 44.8+10.2%, which improved to 58.4+11.9% at follow-up (22+41 days);
p=0.004. All 7 patients with available follow-up had resolution of wall motion abnormali-
ties (29+45 days). Five patients developed left heart failure requiring treatment. All
patients were alive at a median follow-up of 6.5 months (range 1-17 months).
Conclusion: This is one of the first series reporting TLVABS in a US population. TLVABS
can mimic AMI with ECG changes, elevation of cardiac biomarkers, associated left ven-
tricular dysfunction and in some, clinical heart failure. The short-term prognosis appears
favorable with resolution of LV dysfunction. Further studies including long-term follow-up
are needed.
1127-106 Usefulness of Tissue Doppler Imaging for Evaluating 
Systolic and Diastolic Left Ventricular Function in 
Patients With Primary Cardiac Amyloidosis
Jing Ping Sun, John A. Sallach, Neil L. Greenberg, William J. Stewart, Gordan Srkalovic, 
James D. Thomas, Allan L. Klein, The Cleveland Clinic Foundation, Cleveland, OH
Background: Cardiac amyloidosis is associated with increased left ventricular (LV) wall
thickness, normal or decreased LV cavity size, and congestive heart failure (CHF) with
normal or mildly reduced LV ejection fraction. Aim:To clarify whether tissue Doppler
imaging at multiple left ventricular LV sites could help estimate LV systolic and diastolic
function in patients with primary amyloidosis. Methods and Results: Standard 2-D, Dop-
pler and tissue Doppler echocardiographic study was performed in 12 consecutive
patients with primary amyloidosis confirmed by biopsy and 12 matched (age 62±14, 8
males in both groups) normal volunteers. The data were on-line or off-line analyzed using
Vivid 7, GE and Echo Pac. The parameters are present average segmental values as
mean±SD, T test was used for comparison. The diastolic functions of patients with pri-
mary amyloidosis were abnormal (6 were relaxation impaired; 3 were seudonormal; and
4 were restrictive). Tissue Doppler data were different between three types, but not sig-
nificantly; which may due to limited cases number. 
IST=interventricular septal thickness, PWT=LV posterior wall thickness, LV EF=LV ejec-
tion fraction. TK=myocardial displacement, STRs=systolic strain rate, STR=strain rate.
Conclusion: Cardiac amyloidosis is charaterized.by an early impaired in systolic and 
diastolic function. These abnormalities precedes the onset of congestive heart failure 
and can be detected by tissue Doppler velocity, displacement, strain rate and strain 
1127-107 Different Criteria of Cardiac Resynchronization Therapy 
Have Different Prognostic Value for Worsening Heart 
Failure or Major Arrhythmic Events in Idiopathic Dilated 
Cardiomyopathy
Laurent Fauchier, Julien Douglas, Dominique Babuty, Olivier Marie, Pierre Cosnay, Pierre 
Bonnet, Jean Paul Fauchier, Centre Hospitalier Universitaire Trousseau, Tours, France
Cardiac resynchronization therapy (CRT) with biventricular pacing (biV) improves cardiac
symptoms in heart failure patients with dilated cardiomyopathy. There are still controver-
sies about pertinent criteria for CRT and about prophylactic indications of biV cardio-
verter defibrillator.
Methods. In 201 patients with idiopathic dilated cardiomyopathy (IDC) in sinus rhythm
(WHO criteria; age 51±12 years; left ventricular ejection fraction 32±12%), the relative
risk of 1) cardiac death due to heart failure or heart transplantation and 2) sudden death
or sustained ventricular tachycardia (VT) or fibrillation (VF) were calculated separately
according to the inclusion criteria in the MUSTIC, InSync, MIRACLE and CONTAK stud-
ies.
Results. The percentage of patients meeting the inclusion criteria was respectively 6%
for MUSTIC, 7.5 % for InSync, 10 % for MIRACLE and 23 % for CONTAK. With a follow-
up of 51±42 months, 28 patients suffered cardiac death (15 progressive CHF, 13 sudden
deaths), 20 underwent heart transplantation and 12 had sustained VT/VF. Relative risks
of events are in table. Major arrhythmic events were 16 % of all the cardiac events for the
MUSTIC patients, 11% for InSync, 36 % for MIRACLE and 42 % for CONTAK.
Conclusion. In IDC, the patients with the less restrictive inclusion criteria of CRT had the
highest risk of major arrhythmic events. By contrast, severe HF patients with the MUSTIC
criteria of CRT mainly had a risk of worsening heart failure and may not benefit from biV
cardiverter defibrillator.
1127-108 Characteristics of Takotsubo Cardiomyopathy: First US 
Population-Based Report
Amish J. Desai, Milind R. Dhond, Mary Rose Fabi, Richard J. Valente, Ezra A. 
Amsterdam, University of California, Davis, Sacramento, CA
Background: Takotsubo Cardiomyopathy (TC) has been previously described in the Jap-
anese and more recently European literature.This is the first report of this condition in a
US population. TC is characterized by (1) suspected acute MI based on symptoms, elec-
trocardiographic (ECG) changes, and increased cardiac serum markers; (2) hyokinesis/
akinesis of mid to apical left ventricle (LV) and hyperkinesis of the basal LV on ventricu-
lography, (3) < 75% stenoses in the major coronary arteries, and (4) improvement of LV
function on follow-up.
Methods: From January 2002-August 2003 we admitted 9 patients with features consis-
tent with TC. All patients met all 4 criteria for the diagnosis of TC. Data on prestentation
included patient characteristics, complete hemodynamic assessment, coronary and LV
angiography and echocardiography.
Results: Mean patient age was 60.5 years, and 6 were women (66%). Cardiac risk fac-
tors: 7/9 (78%) had hypertension, 2/9 (22%) had diabetes, 2/9 (22%) were smokers, 2/9
(22%) had a family history of premature coronary heart disease, and 3/9 (33%) had
treated hypothyroidism. ECG revealed ST elevation in 3/9 (33%), and T wave changes in
6/9 (66%). At presentation, mean ejection fraction was 32.5%, mean wedge pressure
was 12.7 mm Hg and cardiac output of 3.14 L/min. 8/9 (88%) patients had physiologic
stressors at the time of presentation with 1/9 having an intense emotional stressor. Coro-
nary angiography was normal in all patients and left ventriculography revealed the char-
acteristic Takotsubo (octopus trap) shape. At a mean follow-up of 6 + 2 months all
patients were alive with a mean EF of 49%.
Conclusions: Takotsubo Cardiomyopathy is an unusual and probably underdiagnosed
entity. Our data from the first American cohort confirm prior reports of a clinical presenta-
Standard 
Echo LVD(cm) IST(cm) PWT(c
m)
 EF(%)
LAarea 
(cm2) DT(msec) E/Amitral
Normal 4.7±0.6 1.0±0.2 1.0±0.2 64±7 16±4 201±28 1.2±0.5
Amyoloid 4.0±0.7 1.8±0.2 1.7±0.4 57±3 25±7 167±54 1.9±1.0
p 0.02 <0.0001 <0.0001 0.02 <0.0001 0.10 0.12
Tissue 
Doppler 
Echo
LVS 
velocity(cm/
sec)
LV 
velocityE/
A
LVTK(c
m)
STRs(1/
s)
LV 
STRE/A
LV Systolic 
Strain (%) LV 
StrainE/
A
Normal 4.5±1.0 1.9±1.2 0.8±0.2 -1.1±0.3 1.6±0.4 -19±4 1.6±1.1
Amyoloid 3.0±1.4 4.4±1.9 0.4±0.2 -0.8±0.4 3.5±3.2 -10±5 2.7±0.8
p 0.01 0.01 <0.0001 0.02 0.04 <0.0001 0.01
NYH
A
LV EDD LV EF QRS RR (95% CI) HF 
events
p RR (95% CI) 
Arrhythmic events
p
MUSTIC III >60 mm <35 % >150 ms 4.63 (1.76-12.19) 0.0019 1.16 (0.15-8.70) 0.89
InSync III-IV >60 mm <35 % >150 ms 4.27 (1.85-9.90) 0.0007 1.45 (0.19-11.10) 0.72
MIRACLE III-IV >55 mm <35 % >130 ms 3.14 (1.41-6.99) 0.005 1.83 (0.63-5.35) 0.55
CONTAK II-IV <35 % >120 ms 3.67 (1.85-7.29) 0.0002 2.65 (1.19-5.95) 0.018
